No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
CRVS, CTMX and NRXP Are Among Premarket Gainers
InterCure Reports FY Results
Intercure Ltd. Files April SEC Report
Express News | InterCure FY23 Revenue NIS356M
Express News | InterCure Ltd - Expects Sequential Double Digit Quarterly Growth During 2024
Press Release: InterCure Announces FY2023 Results: Revenue of NIS 356 Million and Adjusted EBITDA of NIS 61 Million
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million -- Revenues during 2023 reached NIS 356 million, alongside an Adjusted EBITDA1 of NIS 61